Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:20 pm Sale |
2020-12-31 | 13D | ADURO BIOTECH, INC ADRO |
Morningside Venture (VI) Investments Ltd | 2,984,605 7.080% |
-11,923,426 (-79.98%) |
Filing History |
| 2021-02-12 4:30 pm Purchase |
2020-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Vivo Capital IX, LLC | 987,624 2.300% |
987,624 (New Position) |
Filing History |
| 2021-02-10 6:21 pm Purchase |
2020-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Renaissance Technologies LLC | 836,086 1.980% |
836,086 (New Position) |
Filing History |
| 2020-11-16 4:14 pm Purchase |
2020-10-05 | 13G | Chinook Therapeutics, Inc. KDNY |
ATP Life Science Ventures L.P. | 4,028,937 9.600% |
4,028,937 (New Position) |
Filing History |
| 2020-11-09 4:23 pm Sale |
2020-10-31 | 13G | ADURO BIOTECH, INC ADRO |
BlackRock Inc. BLK |
0 0.000% |
-4,364,955 (Position Closed) |
Filing History |
| 2020-10-15 5:16 pm Purchase |
2020-10-05 | 13D | Chinook Therapeutics, Inc. KDNY |
Versant Venture Capital VII L.P. | 4,733,023 11.200% |
4,733,023 (New Position) |
Filing History |
| 2020-06-11 5:27 pm Purchase |
2020-02-21 | 13G | ADURO BIOTECH, INC ADRO |
Vivo Capital IX, LLC | 4,184,776 5.200% |
4,184,776 (New Position) |
Filing History |